How to read the result
| Score | Survival 6 months after ECMO, derivation (138 patients) |
|---|
| 0-12 | 80% |
| 13-18 | 58% |
| 19-22 | 25% |
| 23-27 | 20% |
| 28 or more | 7% |
The score describes patients already on VA-ECMO and should not decide on its own whether to start it. Its authors called for prospective validation, and the Tours validation notes that using it to select patients for VA-ECMO is an extrapolation. In the ECLS-SHOCK trial, routine early ECLS did not lower 30-day mortality in infarct-related cardiogenic shock with planned early revascularization (47.8% against 49.0%), with more bleeding and vascular complications in the ECLS group.
Scoring
| Factor before ECMO | Points |
|---|
| Age older than 60 years | 5 |
| Female sex | 7 |
| Body mass index above 25 kg/m2 | 6 |
| Glasgow Coma Scale below 6 | 6 |
| Creatinine above 150 µmol/L (1.7 mg/dL) | 5 |
| Lactate below 2 / 2-8 / above 8 mmol/L | 0 / 8 / 11 |
| Prothrombin activity below 50% | 5 |
Points as reproduced in Semaan 2021 (Supplementary Table S1) and Wang 2021 (Table 5), which agree on every value; the derivation paper is not open access. The Glasgow Coma Scale is the last value recorded while the patient could be assessed, before intubation or while awake. Prothrombin activity is the Quick value in percent, not the INR. Totals run from 0 to 45.
Validation
The score was derived in 138 adults treated with VA-ECMO for acute myocardial infarction with cardiogenic shock in two French ICUs (2008-2013), 47% of whom survived to ICU discharge. Its AUC was 0.84, better than the SAVE, SAPS II and SOFA scores in the same patients. In 51 patients with STEMI-related shock on VA-ECMO at Tours, France, it again discriminated best of the scores tested (AUC above 0.8). Both cohorts are small, single-country and retrospective.
References
- Muller G, Flecher E, Lebreton G, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016;42(3):370-378. PMID 26825953
- Semaan C, Charbonnier A, Pasco J, et al. Risk scores in ST-segment elevation myocardial infarction patients with refractory cardiogenic shock and veno-arterial extracorporeal membrane oxygenation. J Clin Med. 2021;10(5):956. PMID 33804450
- Wang J, Shen B, Feng X, et al. A review of prognosis model associated with cardiogenic shock after acute myocardial infarction. Front Cardiovasc Med. 2021;8:754303. PMID 34957245
- Thiele H, Zeymer U, Akin I, et al. Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med. 2023;389(14):1286-1297. PMID 37634145